The 12 weeks, randomized, double-blinded, placebo-controlled human study to evaluate the effectiveness and safety of KGC deer antlers on the growth of children.
Sang Min KimJin Yong LeeGyu Tae ChangSu Min HwangboSun Haeng LeePublished in: Medicine (2022)
This clinical trial is designed to be conducted on 100 children aged 3 to 12 years for 12 weeks (Trial registration code: KCT0007386). We will evaluate changes in height, height percentile, standard deviation score of height, weight, body mass index, waist circumference, hip circumference, bone age, predicted adult height estimated by bone age, human growth hormone level, insulin-like growth factor-1 (IGF-1) level, IGF-binding protein-3 (IGFBP-3) level, IGF-1/IGFBP-3 ratio, and estradiol level. Additionally, we also will evaluate the adverse events during the study.
Keyphrases
- body mass index
- growth hormone
- binding protein
- clinical trial
- double blind
- weight gain
- placebo controlled
- phase iii
- phase ii
- endothelial cells
- physical activity
- study protocol
- open label
- bone mineral density
- induced pluripotent stem cells
- squamous cell carcinoma
- body weight
- postmenopausal women
- soft tissue
- radiation therapy
- gestational age